Insmed Incorporated (INSM) analyst actions
Rating and price-target actions on INSM in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the INSM overview →
1 measured INSM analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Insmed Incorporated (INSM) And Encourages Stockholders to Reach Out | Press release | +0.08% | +1.94% |
Keep exploring
More INSM: earnings → · SEC filings → · INSM overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Synthetic Biologics, Inc. (SYN) | 703 | -0.34% | 41% |
| PishPosh, Inc. (BABY) | 702 | 0.00% | 48% |
| Revance Therapeutics, Inc. (RVNC) | 701 | 0.00% | 42% |
| AB Corporate Bond ETF (EYEG) | 700 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.